The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema

PURPOSE: To assess efficacy and safety of intravitreal ranibizumab 0.5 mg plus laser (COMBI) versus laser monotherapy (LASER) in patients with visual impairment due to diabetic macular oedema (DME) in either nonproliferative diabetic retinopathy (NPDR) or proliferative diabetic retinopathy (PDR) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Gabriele E., Liakopoulos, Sandra, Vögeler, Jessica, Weiß, Claudia, Spital, Georg, Gamulescu, Maria‐Andreea, Lohmann, Chris, Wiedemann, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947710/
https://www.ncbi.nlm.nih.gov/pubmed/29090846
http://dx.doi.org/10.1111/aos.13574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947710/
https://www.ncbi.nlm.nih.gov/pubmed/29090846
http://dx.doi.org/10.1111/aos.13574

Ejemplares similares